Table S2 from TTK Inhibitors as a Targeted Therapy for CTNNB1 (β-catenin) Mutant Cancers

Autor: Joost C.M. Uitdehaag, Rogier C. Buijsman, Jos de Man, Martine B.W. Prinsen, Marion A.A. Libouban, Jeroen A.D.M. de Roos, Guido J.R. Zaman
Rok vydání: 2023
Popis: Reanalyis of cell panel profilings of TTK inhibitors from literature
Databáze: OpenAIRE